CASP3 and rheumatoid arthritis: It has been reported to stimulate the proliferation of T cells and the release of IL-10, accompanied by the upregulation of TNF apoptosis-inducing ligand and caspase-3, resulting in abnormal responses of T cells associated with aggravated RA (62).